The Connective Tissue Disorder Associated with Recessive Variants in the SLC39A13 Zinc Transporter Gene (Spondylo-Dysplastic Ehlers–Danlos Syndrome Type 3): Insights from Four Novel Patients and Follow-Up on Two Original Cases
Open Access
- 13 April 2020
- Vol. 11 (4), 420
- https://doi.org/10.3390/genes11040420
Abstract
Recessive loss-of-function variants in SLC39A13, a putative zinc transporter gene, were first associated with a connective tissue disorder that is now called “Ehlers–Danlos syndrome, spondylodysplastic form type 3” (SCD-EDS, OMIM 612350) in 2008. Nine individuals have been described. We describe here four additional affected individuals from three consanguineous families and the follow up of two of the original cases. In our series, cardinal findings included thin and finely wrinkled skin of the hands and feet, characteristic facial features with downslanting palpebral fissures, mild hypertelorism, prominent eyes with a paucity of periorbital fat, blueish sclerae, microdontia, or oligodontia, and—in contrast to most types of Ehlers–Danlos syndrome—significant short stature of childhood onset. Mild radiographic changes were observed, among which platyspondyly is a useful diagnostic feature. Two of our patients developed severe keratoconus, and two suffered from cerebrovascular accidents in their twenties, suggesting that there may be a vascular component to this condition. All patients tested had a significantly reduced ratio of the two collagen-derived crosslink derivates, pyridinoline-to-deoxypyridinoline, in urine, suggesting that this simple test is diagnostically useful. Additionally, analysis of the facial features of affected individuals by DeepGestalt technology confirmed their specificity and may be sufficient to suggest the diagnosis directly. Given that the clinical presentation in childhood consists mainly of short stature and characteristic facial features, the differential diagnosis is not necessarily that of a connective tissue disorder and therefore, we propose that SLC39A13 is included in gene panels designed to address dysmorphism and short stature. This approach may result in more efficient diagnosis.This publication has 11 references indexed in Scilit:
- Identifying facial phenotypes of genetic disorders using deep learningNature Medicine, 2019
- Further delineation of Aymé‐Gripp syndrome and use of automated facial analysis toolAmerican Journal of Medical Genetics Part A, 2018
- Novel Nonsense Mutation in SLC39A13 Initially Presenting as Myopathy: Case Report and Review of the LiteratureMolecular Syndromology, 2018
- The 2017 international classification of the Ehlers–Danlos syndromesSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2017
- Correction: The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling PathwaysPLOS ONE, 2008
- The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling PathwaysPLOS ONE, 2008
- Spondylocheiro Dysplastic Form of the Ehlers-Danlos Syndrome—An Autosomal-Recessive Entity Caused by Mutations in the Zinc Transporter Gene SLC39A13American Journal of Human Genetics, 2008
- Roles of Zinc and Zinc Signaling in Immunity: Zinc as an Intracellular Signaling MoleculeAdvances in Immunology, 2008
- The Ehlers‐Danlos SyndromePublished by Wiley ,2002
- Ehlers-Danlos syndrome.Annals Of The Rheumatic Diseases, 1970